building-merger-consequence-models
Constructs accretion/dilution analysis with pro forma financials, synergy phasing, and purchase price allocation. Use when modeling merger outcomes, calculating EPS accretion, or analyzing deal structures.
Best use case
building-merger-consequence-models is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Constructs accretion/dilution analysis with pro forma financials, synergy phasing, and purchase price allocation. Use when modeling merger outcomes, calculating EPS accretion, or analyzing deal structures.
Teams using building-merger-consequence-models should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/building-merger-consequence-models/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How building-merger-consequence-models Compares
| Feature / Agent | building-merger-consequence-models | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Constructs accretion/dilution analysis with pro forma financials, synergy phasing, and purchase price allocation. Use when modeling merger outcomes, calculating EPS accretion, or analyzing deal structures.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
# Building Merger Consequence Models ## When To Use - Evaluating whether a proposed acquisition is accretive or dilutive to acquirer EPS - Modeling pro forma combined financial statements for board presentations or fairness opinions - Stress-testing deal structures across varying consideration mixes (cash vs. stock vs. mixed) - Phasing synergy realization schedules for integration planning - Analyzing purchase price allocation (PPA) impact on goodwill, intangibles, and future amortization - Comparing multiple deal scenarios (e.g., different offer prices, financing structures, or synergy assumptions) ## Inputs To Gather **Acquirer financials:** - Latest reported and consensus forecast EPS, net income, shares outstanding, share price - Existing debt balances, interest rates, cash position, and tax rate - Current P/E multiple and market capitalization **Target financials:** - Latest reported and consensus forecast EPS, net income, shares outstanding, share price - Revenue and EBITDA for synergy sizing baseline - Existing debt to be assumed or refinanced **Deal terms:** - Offer price per share or total equity value - Consideration mix: % cash, % stock, any CVRs or earnouts - Expected transaction and financing fees - Assumed financing terms for any new debt (rate, tenor, amortization) **Synergy assumptions:** - Cost synergies: run-rate amount, phase-in schedule (typically 25%/50%/75%/100% over Years 1–4) - Revenue synergies (if modeled): run-rate amount, phase-in, associated costs to achieve - One-time integration/restructuring costs and their timing - Tax treatment of synergies and integration costs **PPA estimates:** - Fair value step-ups for tangible and identifiable intangible assets - Estimated useful lives for amortizable intangibles (customer relationships, technology, trade names) - Deferred tax liability created by asset step-ups [VERIFY: tax rate and jurisdiction rules] ## Workflow 1. **Build standalone projections** — Set up acquirer and target income statements on a consistent basis (same fiscal year, same line-item granularity). Calendarize if fiscal years differ. Normalize for non-recurring items. 2. **Calculate purchase price and goodwill** — Compute equity offer value, add assumed net debt to get enterprise value. Allocate purchase price: fair value of net tangible assets + identifiable intangibles + residual goodwill. Compute any deferred tax liabilities from step-ups. 3. **Model financing structure** — For cash consideration: determine funding source (cash on hand, new debt, or mix). Calculate incremental interest expense net of foregone interest income on cash used. For stock consideration: compute new shares issued using the exchange ratio (offer price / acquirer share price). For mixed deals: model both components. 4. **Construct pro forma income statement** — Combine acquirer + target standalone projections. Layer in adjustments: - (+) Cost synergies per phase-in schedule, net of tax - (+) Revenue synergies (if included), net of associated costs and tax - (−) Incremental intangible amortization from PPA - (−) Incremental interest expense from acquisition debt - (+) Interest income saved on target's refinanced debt (if applicable) - (−) One-time integration costs (typically excluded from recurring accretion/dilution but shown separately) - Apply blended effective tax rate to pre-tax adjustments [VERIFY: combined entity tax rate] 5. **Calculate accretion/dilution** — Compute pro forma EPS = pro forma net income / pro forma diluted shares outstanding. Compare to acquirer standalone EPS. Express result as % accretive or dilutive for each projection year. Show both with and without synergies to isolate synergy contribution. 6. **Run sensitivity analysis** — Build tables varying: - Offer price (±5–15% range) - Consideration mix (0%/25%/50%/75%/100% stock) - Synergy realization level (50%/75%/100%/125% of base case) - Interest rate on acquisition financing (±50–150 bps) - Breakeven synergy required to achieve EPS neutrality 7. **Prepare output tables** — Format results for presentation: summary accretion/dilution by year, pro forma EPS bridge (waterfall from standalone to pro forma), sensitivity matrices, and PPA summary. ## Output - **Accretion/dilution summary**: Year 1–3 (or longer) showing pro forma EPS vs. standalone EPS, $ and % impact, with and without synergies - **Pro forma income statement**: Combined P&L with clearly labeled merger adjustments as separate line items - **EPS bridge / waterfall**: Standalone acquirer EPS → target earnings contribution → synergies → financing cost → amortization → pro forma EPS - **Purchase price allocation table**: Fair values assigned to tangible assets, identifiable intangibles (by category and useful life), goodwill, and associated deferred tax impacts - **Synergy phase-in schedule**: Annual run-rate build, costs to achieve, and net after-tax contribution - **Sensitivity tables**: Accretion/dilution across offer price, consideration mix, synergy level, and financing cost scenarios - **Key assumptions page**: All inputs, sources, and items flagged [VERIFY] ## Quality Checks - **EPS math integrity**: Pro forma net income / pro forma shares = stated pro forma EPS (no rounding shortcuts) - **Shares outstanding consistency**: New shares issued in stock deals = target shares × exchange ratio; verify diluted share count includes in-the-money target options converted at the exchange ratio - **Goodwill reasonableness**: Total PPA should equal purchase price; goodwill should not be negative unless a bargain purchase is intended [VERIFY: bargain purchase gain treatment under ASC 805] - **Tax consistency**: Verify the same tax rate is applied to synergies, amortization add-backs, and interest adjustments; confirm treatment of non-deductible goodwill - **Synergy double-counting**: Ensure cost synergies are not also embedded in target's standalone projections - **Financing circularity**: If using acquirer stock, confirm share price assumption is consistent (fixed vs. floating exchange ratio); if debt-funded, confirm interest rate reflects current market for acquirer's credit profile [VERIFY] - **Sign conventions**: Accretive = positive (pro forma EPS > standalone); dilutive = negative — confirm this is consistent throughout all tables - **Cross-check**: Compare implied transaction multiples (EV/EBITDA, P/E on offer) to precedent transactions for reasonableness